Law360, New York ( December 6, 2012, 4:21 PM EST) -- First, there was Mayo v. Prometheus,[1] where the Supreme Court found the medical diagnostic methods at issue were not patentable subject matter. Then, the court sent Myriad[2] back to the Federal Circuit, for further consideration of whether isolated DNA sequences are patentable. It will soon hear that case again — certiorari was just granted....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.